Biomind Labs Inc (BMND) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.042x

Based on the latest financial reports, Biomind Labs Inc (BMND) has a cash flow conversion efficiency ratio of 0.042x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-79.04K ≈ $-57.17K USD) by net assets (CA$-1.90 Million ≈ $-1.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Biomind Labs Inc for the company's overall valuation and market capitalisation.

Biomind Labs Inc - Cash Flow Conversion Efficiency Trend (2021–2025)

This chart illustrates how Biomind Labs Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Biomind Labs Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Biomind Labs Inc ranked by their cash flow conversion efficiency. Explore Biomind Labs Inc earnings quality ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Arribatec Solutions ASA
OL:ARR
0.035x
WT Financial Group Ltd
AU:WTL
0.125x
IFirma SA
WAR:IFI
0.126x
Orient Paper & Industries Limited
NSE:ORIENTPPR
-0.008x
Ta Jiang Co Ltd
TW:1453
-0.077x
CHUNGDAHM Learning Inc
KQ:096240
-0.110x
Song Ho Industrial Co Ltd
TWO:5016
0.013x
Acanthe Développement
PA:ACAN
-0.049x

Annual Cash Flow Conversion Efficiency for Biomind Labs Inc (2021–2025)

The table below shows the annual cash flow conversion efficiency of Biomind Labs Inc from 2021 to 2025. View BMND stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CA$-1.74 Million
≈ $-1.26 Million
CA$-67.55K
≈ $-48.86K
0.039x -85.72%
2024-12-31 CA$-1.30 Million
≈ $-940.54K
CA$-354.43K
≈ $-256.39K
0.273x -49.03%
2023-12-31 CA$-1.43 Million
≈ $-1.04 Million
CA$-765.93K
≈ $-554.06K
0.535x -93.84%
2022-12-31 CA$-247.66K
≈ $-179.15K
CA$-2.15 Million
≈ $-1.56 Million
8.685x +997.29%
2021-12-31 CA$2.19 Million
≈ $1.59 Million
CA$-2.12 Million
≈ $-1.54 Million
-0.968x --

About Biomind Labs Inc

NEO:BMND Canada Biotechnology
Market Cap
$38.72 Million
CA$53.52 Million CAD
Market Cap Rank
#22935 Global
#834 in Canada
Share Price
CA$0.69
Change (1 day)
+0.00%
52-Week Range
CA$0.01 - CA$0.69
All Time High
CA$1.90
About

Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions. The company is developing BMND01, which is in Phase II clinical trials for use in the treatment of depression; BMND08, a 5-Metoxi-N,N-dimethyltryptamine sublingual formulation that is in Phase II clinical… Read more